Angiotensin receptor blockers (ARBs) vs. angiotensin-converting enzyme inhibitors (ACEi) treatment in hypertension: what is the evidence to date? Part 2

Angiotensin receptor blockers (ARBs) vs. angiotensin-converting enzyme inhibitors (ACEi) treatment in hypertension: what is the evidence to date? In part 2, Professor Williams addresses whether there are any differences in the safety and persistence of ARBs and ACEi and what challenges are faced when both treatment classes are combined.
Login/ Register Maximise Minimise